|
|
Volumn 22 Suppl 1, Issue , 1997, Pages 40-50
|
|
Clinico-electrophysiologic effects of magnesium, especially in supraventricular tachycardia;Klinisch-elektrophysiologische Effekte von Magnesium, insbesondere bei supraventrikulären Tachykardien.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
MAGNESIUM;
VERAPAMIL;
ADULT;
AGED;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFECT;
ELECTROCARDIOGRAPHY;
FEMALE;
HEART MUSCLE CONDUCTION SYSTEM;
HEART VENTRICLE FIBRILLATION;
HUMAN;
MALE;
MIDDLE AGED;
PATHOPHYSIOLOGY;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SINGLE BLIND PROCEDURE;
SUPRAVENTRICULAR TACHYCARDIA;
ADULT;
AGED;
ANTI-ARRHYTHMIA AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ELECTROCARDIOGRAPHY;
FEMALE;
HEART CONDUCTION SYSTEM;
HUMANS;
MAGNESIUM;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
SINGLE-BLIND METHOD;
TACHYCARDIA, SUPRAVENTRICULAR;
VENTRICULAR FIBRILLATION;
VERAPAMIL;
MLCS;
MLOWN;
|
|
EID: 0031155178
PISSN: 03409937
EISSN: None
Source Type: Journal
DOI: 10.1007/bf03042654 Document Type: Review |
|
Times cited : (11)
|
|
References (33)
|
